This contract, awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, provides for the delivery of the pharmaceutical product QULIPTA 60 MG TABLET 30S. The contract has a ceiling value of $11,738.78 and a period of performance through December 20, 2024.
Dakota Drug, Inc. is an established federal contractor that has been awarded a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT Generation V Program. This IDC enables the company to efficiently deliver a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. The present contract award is not set-aside and appears to be part of the company's broader portfolio of federal contract work with the DLA.
Generated 3/20/25, 9:56 AM